Table 2.
Comparison of microvascular density in the SCP and DCP using OCTA between baseline and after the intravitreal anti-VEGF injections.
| M0 | M3 | P | |
|---|---|---|---|
| SCP | |||
| Fovea | 17.22 ± 7.10 | 15.24 ± 7.78 | 0.10 |
| Parafovea | 43.02 ± 5.90 | 42.03 ± 5.78 | 0.32 |
| Whole | 40.40 ± 6.11 | 39.59 ± 5.94 | 0.44 |
| DCP | |||
| Fovea | 26.85 ± 8.50 | 25.84 ± 8.24 | 0.58 |
| Parafovea | 44.42 ± 6.17 | 47.08 ± 5.99 | 0.08 |
| Whole | 42.96 ± 5.48 | 44.52 ± 4.58 | 0.24 |
Data are shown as mean ± standard deviation. ∗Significant at P < 0.05. M0, baseline; M3, 3 consecutive monthly anti-VEGF injections. DCP: deep retinal capillary plexus; HRF: hyperreflective foci; SCP: superficial retinal capillary plexus; VEGF: vascular endothelial growth factor.